|
 |
2010/07/01/NOVITA THERAPEUTICS GETS ALMOST 1M IN INVESTMENTS TO TEST HEART DEVICE BIZJOURNALS COM/
The page is no longer available. You may want to read the following pages.
H Kurazumi, A Mikamo, G Fukamitsu... - ... Cardiovascular Surgery, 2011 - Springer Abstract Purpose. Recent studies have shown that the European System for Cardiac Operative
Risk Evaluation (Euro- SCORE) is a reliable risk model in cardiac surgery. In Japan, the Japan SCORE
has been devised as the Japa- nese original risk model for cardiovascular surgery. We ...
MJE Parry, J Watt-Watson, ED Hodnett, JE Tranmer... - 2011 - A Pilot Trial of a Home-Based Peer Support Program to Aid Recovery Post Coronary Artery Bypass Graft Surgery Conference Sponsor: Sigma Theta Tau International Conference Year: 2007 Author: Parry, Monica JE, RN, Ph D (c), ACNP, CCN (C) PI Institution Name: ...
JJCB Ad, KA Pieter... - 2011 - Abstract Antiplatelet and anticoagulant therapy is a key part of the management of patients undergoing cardiac surgery and one of the cornerstones to prevent complications after coronary bypass or valvular heart surgery. The use of anticoagulants and antiplatelets is ...
DO Wilson - Redo Cardiac Surgery in Adults, 2012 - Springer Pulmonary factors are quite relevant for redo cardiac surgery. Postoperative pulmonary complications contribute significantly to overall perioperative morbidity and mortality. This section will review preoperative and postoperative pulmonary considerations in patients ... [HTML]
C Wu, FT Camacho, AT Culliford... - ... Quality and Outcomes, 2012 - Am Heart Assoc Background The survival difference between off-pump and on-pump coronary artery bypass graft surgery for follow-up longer than 5 years is not well-understood. The objective of this study is to examine the difference in 7-year mortality after these 2 procedures.
|
|
|
